Advertisement

Utility of cardiac magnetic resonance imaging, echocardiography and electrocardiography for the prediction of clinical response and long-term survival following cardiac resynchronisation therapy

  • Andris H. Ellims
  • Heinz Pfluger
  • Maros Elsik
  • Michelle J. Butler
  • James L. Hare
  • Andrew J. Taylor
Original Paper

Abstract

Cardiac resynchronisation therapy (CRT) can reduce symptoms, hospitalisations, and mortality in patients with severe left ventricular (LV) systolic dysfunction and electro-mechanical dyssynchrony. Unfortunately, approximately 30 % of eligible patients fail to respond to CRT. This study prospectively compared electrocardiography (ECG), echocardiography, and cardiac magnetic resonance (CMR) imaging for the prediction of response to CRT. We performed ECG, echocardiography and CMR on 46 patients prior to planned CRT implantation. Patients were divided into predicted responder and non-responder groups using previously described criteria for each modality. Changes in indicators of CRT response were recorded 6 months post-implantation, and later for transplant-free survival. Less dyspnoea, lower levels of N-terminal pro-brain natriuretic peptide, more LV reverse remodelling, and longer transplant-free survival were observed in predicted responders compared to predicted non-responders using each of the three modalities (p < 0.05 for each comparison). Additionally, for patients with QRS duration <150 ms and/or non-left bundle branch block (non-LBBB) QRS morphology, CMR predicted both clinical response and improved longer term transplant-free survival (80 % transplant-free survival in predicted responders vs. 20 % in predicted non-responders, p = 0.04). ECG and cardiac imaging techniques predict improvements in markers of response following CRT with similar accuracy. However, for CRT candidates with shorter, non-LBBB QRS complexes, a subgroup known to derive less benefit from CRT, CMR may predict those who are more likely to gain both symptomatic and survival benefits.

Keywords

Cardiomyopathy Cardiac magnetic resonance imaging Echocardiography Cardiac resynchronisation therapy 

Notes

Acknowledgments

Dr Ellims is supported by a combined Heart Foundation of Australia and National Heart and Medical Research Council Postgraduate Research Scholarship. Dr Hare is supported by a Cardiac Society of Australia and New Zealand Research Investigatorship. Dr Taylor is supported by a National Health and Medical Research Council program grant, and a Heart Foundation of Australia project grant.

Conflict of interest

Andris Ellims, Heinz Pfluger, Maros Elsik, Michelle Butler, James Hare, and Andrew Taylor declare that they have no conflict of interest.

Ethical standards

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. Informed consent was obtained from all patients for being included in the study.

References

  1. 1.
    Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Riegel B, Tarkington LG, Yancy CW (2008) ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and Antiarrhythmia Devices): developed in collaboration with the American association for thoracic surgery and society of thoracic surgeons. Circulation 117(21):e350–e408. doi: 10.1161/CIRCUALTIONAHA.108.189742 PubMedCrossRefGoogle Scholar
  2. 2.
    Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R (1994) Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 344(8921):493–498PubMedCrossRefGoogle Scholar
  3. 3.
    Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW (2009) 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the international society for heart and lung transplantation. Circulation 119(14):e391–e479. doi: 10.1161/CIRCULATIONAHA.109.192065 PubMedCrossRefGoogle Scholar
  4. 4.
    Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J, Ponikowski P, Priori SG, Sutton R, van Veldhuisen DJ (2010) 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur Heart J 31(21):2677–2687. doi: 10.1093/eurheartj/ehq337 PubMedCrossRefGoogle Scholar
  5. 5.
    Bradley DJ, Bradley EA, Baughman KL, Berger RD, Calkins H, Goodman SN, Kass DA, Powe NR (2003) Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA 289(6):730–740PubMedCrossRefGoogle Scholar
  6. 6.
    Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352(15):1539–1549. doi: 10.1056/NEJMoa050496 PubMedCrossRefGoogle Scholar
  7. 7.
    Rivero-Ayerza M, Theuns DA, Garcia–Garcia HM, Boersma E, Simoons M, Jordaens LJ (2006) Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. Eur Heart J 27(22):2682–2688. doi: 10.1093/eurheartj/ehl203 PubMedCrossRefGoogle Scholar
  8. 8.
    McAlister FA, Ezekowitz JA, Wiebe N, Rowe B, Spooner C, Crumley E, Hartling L, Klassen T, Abraham W (2004) Systematic review: cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med 141(5):381–390PubMedCrossRefGoogle Scholar
  9. 9.
    Saxon LA, Ellenbogen KA (2003) Resynchronization therapy for the treatment of heart failure. Circulation 108(9):1044–1048. doi: 10.1161/01.CIR.0000085656.57918.B1 PubMedCrossRefGoogle Scholar
  10. 10.
    Bax JJ, Ansalone G, Breithardt OA, Derumeaux G, Leclercq C, Schalij MJ, Sogaard P, St John Sutton M, Nihoyannopoulos P (2004) Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? A critical appraisal. J Am Coll Cardiol 44(1):1–9. doi: 10.1016/j.jacc.2004.02.055 PubMedCrossRefGoogle Scholar
  11. 11.
    Bax JJ, Bleeker GB, Marwick TH, Molhoek SG, Boersma E, Steendijk P, van der Wall EE, Schalij MJ (2004) Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 44(9):1834–1840. doi: 10.1016/j.jacc.2004.08.016 PubMedCrossRefGoogle Scholar
  12. 12.
    Gorcsan J 3rd, Abraham T, Agler DA, Bax JJ, Derumeaux G, Grimm RA, Martin R, Steinberg JS, Sutton MS, Yu CM (2008) Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting–a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. J Am Soc Echocardiogr 21(3):191–213. doi: 10.1016/j.echo.2008.01.003 PubMedCrossRefGoogle Scholar
  13. 13.
    Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio S, Leclercq C, Bax JJ, Yu CM, Gorcsan J 3rd, St John Sutton M, De Sutter J, Murillo J (2008) Results of the predictors of response to CRT (PROSPECT) trial. Circulation 117(20):2608–2616. doi: 10.1161/CIRCULATIONAHA.107.743120 PubMedCrossRefGoogle Scholar
  14. 14.
    Gold MR, Thebault C, Linde C, Abraham WT, Gerritse B, Ghio S, St John Sutton M, Daubert JC (2012) Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the resynchronization reverses remodeling in systolic left ventricular dysfunction (REVERSE) Study. Circulation 126(7):822–829. doi: 10.1161/CIRCULATIONAHA.112.097709 PubMedCrossRefGoogle Scholar
  15. 15.
    Taylor AJ, Elsik M, Broughton A, Cherayath J, Leet A, Wong C, Iles L, Butler M, Pfluger H (2010) Combined dyssynchrony and scar imaging with cardiac magnetic resonance imaging predicts clinical response and long-term prognosis following cardiac resynchronization therapy. Europace 12(5):708–713. doi: 10.1093/europace/euq047 PubMedCrossRefGoogle Scholar
  16. 16.
    Marsan NA, Westenberg JJ, Ypenburg C, van Bommel RJ, Roes S, Delgado V, Tops LF, van der Geest RJ, Boersma E, de Roos A, Schalij MJ, Bax JJ (2009) Magnetic resonance imaging and response to cardiac resynchronization therapy: relative merits of left ventricular dyssynchrony and scar tissue. Eur Heart J 30(19):2360–2367. doi: 10.1093/eurheartj/ehp280 PubMedCrossRefGoogle Scholar
  17. 17.
    White JA, Yee R, Yuan X, Krahn A, Skanes A, Parker M, Klein G, Drangova M (2006) Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol 48(10):1953–1960. doi: 10.1016/j.jacc.2006.07.046 PubMedCrossRefGoogle Scholar
  18. 18.
    Bilchick KC, Dimaano V, Wu KC, Helm RH, Weiss RG, Lima JA, Berger RD, Tomaselli GF, Bluemke DA, Halperin HR, Abraham T, Kass DA, Lardo AC (2008) Cardiac magnetic resonance assessment of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapy. JACC Cardiovasc Imaging 1(5):561–568. doi: 10.1016/j.jcmg.2008.04.013 PubMedCrossRefGoogle Scholar
  19. 19.
    Rector TS, Kubo SH, Cohn JN (1987) Patient’s self-assessment of their congestive heart failure, II: content, reliability and validity of a new measure, The Minnesota Living with Heart Failure Questionnaire. Heart Failure 3:198–209Google Scholar
  20. 20.
    Cazeau S, Bordachar P, Jauvert G, Lazarus A, Alonso C, Vandrell MC, Mugica J, Ritter P (2003) Echocardiographic modeling of cardiac dyssynchrony before and during multisite stimulation: a prospective study. Pacing Clin Electrophysiol 26(1 Pt 2):137–143PubMedCrossRefGoogle Scholar
  21. 21.
    Bax JJ, Marwick TH, Molhoek SG, Bleeker GB, van Erven L, Boersma E, Steendijk P, van der Wall EE, Schalij MJ (2003) Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. Am J Cardiol 92(10):1238–1240PubMedCrossRefGoogle Scholar
  22. 22.
    Taylor AJ, Al-Saadi N, Abdel-Aty H, Schulz-Menger J, Messroghli DR, Friedrich MG (2004) Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance imaging. Circulation 109(17):2080–2085. doi: 10.1161/01.CIR.0000127812.62277.50 PubMedCrossRefGoogle Scholar
  23. 23.
    Sipahi I, Carrigan TP, Rowland DY, Stambler BS, Fang JC (2011) Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. Arch Intern Med 171(16):1454–1462. doi: 10.1001/archinternmed.2011.247 PubMedCrossRefGoogle Scholar
  24. 24.
    Zareba W, Klein H, Cygankiewicz I, Hall WJ, McNitt S, Brown M, Cannom D, Daubert JP, Eldar M, Gold MR, Goldberger JJ, Goldenberg I, Lichstein E, Pitschner H, Rashtian M, Solomon S, Viskin S, Wang P, Moss AJ (2011) Effectiveness of cardiac resynchronization therapy by QRS morphology in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT). Circulation 123(10):1061–1072. doi: 10.1161/CIRCULATIONAHA.110.960898 PubMedCrossRefGoogle Scholar
  25. 25.
    Packer M (2001) Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. J Cardiac Fail 7(2):176–182. doi: 10.1054/jcaf.2001.25652 CrossRefGoogle Scholar
  26. 26.
    Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350(21):2140–2150. doi: 10.1056/NEJMoa032423 PubMedCrossRefGoogle Scholar
  27. 27.
    Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K (2003) Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 289(20):2685–2694. doi: 10.1001/jama.289.20.2685 PubMedCrossRefGoogle Scholar
  28. 28.
    Chalil S, Foley PW, Muyhaldeen SA, Patel KC, Yousef ZR, Smith RE, Frenneaux MP, Leyva F (2007) Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy. Europace 9(11):1031–1037. doi: 10.1093/europace/eum133 PubMedCrossRefGoogle Scholar
  29. 29.
    Ariga R, Tayebjee MH, Benfield A, Todd M, Lefroy DC (2010) Greater three-dimensional ventricular lead tip separation is associated with improved outcome after cardiac resynchronization therapy. Pacing Clin Electrophysiol 33(12):1490–1496. doi: 10.1111/j.1540-8159.2010.02895.x PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Andris H. Ellims
    • 1
    • 2
  • Heinz Pfluger
    • 1
    • 2
  • Maros Elsik
    • 1
    • 2
  • Michelle J. Butler
    • 1
    • 2
  • James L. Hare
    • 1
    • 2
  • Andrew J. Taylor
    • 1
    • 2
  1. 1.Heart CentreAlfred HospitalMelbourneAustralia
  2. 2.Baker IDI Heart and Diabetes InstituteMelbourneAustralia

Personalised recommendations